Global Pemetrexed Drug Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.
LPI (LP Information)' newest research report, the “Pemetrexed Drug Industry Forecast” looks at past sales and reviews total world Pemetrexed Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Pemetrexed Drug sales for 2023 through 2029. With Pemetrexed Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pemetrexed Drug industry.
This Insight Report provides a comprehensive analysis of the global Pemetrexed Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pemetrexed Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pemetrexed Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pemetrexed Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pemetrexed Drug.
The global Pemetrexed Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pemetrexed Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pemetrexed Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pemetrexed Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pemetrexed Drug players cover Eli Lilly and Company, Pfizer, Teva, Eagle Pharmaceuticals, APOTEX, Qilu Pharmaceutical and Biocon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pemetrexed Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pemetrexed Drug market?
What factors are driving Pemetrexed Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pemetrexed Drug market opportunities vary by end market size?
How does Pemetrexed Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.
LPI (LP Information)' newest research report, the “Pemetrexed Drug Industry Forecast” looks at past sales and reviews total world Pemetrexed Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Pemetrexed Drug sales for 2023 through 2029. With Pemetrexed Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pemetrexed Drug industry.
This Insight Report provides a comprehensive analysis of the global Pemetrexed Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pemetrexed Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pemetrexed Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pemetrexed Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pemetrexed Drug.
The global Pemetrexed Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pemetrexed Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pemetrexed Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pemetrexed Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pemetrexed Drug players cover Eli Lilly and Company, Pfizer, Teva, Eagle Pharmaceuticals, APOTEX, Qilu Pharmaceutical and Biocon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pemetrexed Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 100 mg lyophilized powder/vial
- 500 mg lyophilized powder/vial
- Pleural mesothelioma
- Non-small cell lung cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly and Company
- Pfizer
- Teva
- Eagle Pharmaceuticals
- APOTEX
- Qilu Pharmaceutical
- Biocon
What is the 10-year outlook for the global Pemetrexed Drug market?
What factors are driving Pemetrexed Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pemetrexed Drug market opportunities vary by end market size?
How does Pemetrexed Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pemetrexed Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pemetrexed Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pemetrexed Drug by Country/Region, 2018, 2022 & 2029
2.2 Pemetrexed Drug Segment by Type
2.2.1 100 mg lyophilized powder/vial
2.2.2 500 mg lyophilized powder/vial
2.3 Pemetrexed Drug Sales by Type
2.3.1 Global Pemetrexed Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Pemetrexed Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pemetrexed Drug Sale Price by Type (2018-2023)
2.4 Pemetrexed Drug Segment by Application
2.4.1 Pleural mesothelioma
2.4.2 Non-small cell lung cancer
2.5 Pemetrexed Drug Sales by Application
2.5.1 Global Pemetrexed Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Pemetrexed Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pemetrexed Drug Sale Price by Application (2018-2023)
3 GLOBAL PEMETREXED DRUG BY COMPANY
3.1 Global Pemetrexed Drug Breakdown Data by Company
3.1.1 Global Pemetrexed Drug Annual Sales by Company (2018-2023)
3.1.2 Global Pemetrexed Drug Sales Market Share by Company (2018-2023)
3.2 Global Pemetrexed Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Pemetrexed Drug Revenue by Company (2018-2023)
3.2.2 Global Pemetrexed Drug Revenue Market Share by Company (2018-2023)
3.3 Global Pemetrexed Drug Sale Price by Company
3.4 Key Manufacturers Pemetrexed Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pemetrexed Drug Product Location Distribution
3.4.2 Players Pemetrexed Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PEMETREXED DRUG BY GEOGRAPHIC REGION
4.1 World Historic Pemetrexed Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Pemetrexed Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pemetrexed Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pemetrexed Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Pemetrexed Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pemetrexed Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pemetrexed Drug Sales Growth
4.4 APAC Pemetrexed Drug Sales Growth
4.5 Europe Pemetrexed Drug Sales Growth
4.6 Middle East & Africa Pemetrexed Drug Sales Growth
5 AMERICAS
5.1 Americas Pemetrexed Drug Sales by Country
5.1.1 Americas Pemetrexed Drug Sales by Country (2018-2023)
5.1.2 Americas Pemetrexed Drug Revenue by Country (2018-2023)
5.2 Americas Pemetrexed Drug Sales by Type
5.3 Americas Pemetrexed Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pemetrexed Drug Sales by Region
6.1.1 APAC Pemetrexed Drug Sales by Region (2018-2023)
6.1.2 APAC Pemetrexed Drug Revenue by Region (2018-2023)
6.2 APAC Pemetrexed Drug Sales by Type
6.3 APAC Pemetrexed Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pemetrexed Drug by Country
7.1.1 Europe Pemetrexed Drug Sales by Country (2018-2023)
7.1.2 Europe Pemetrexed Drug Revenue by Country (2018-2023)
7.2 Europe Pemetrexed Drug Sales by Type
7.3 Europe Pemetrexed Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pemetrexed Drug by Country
8.1.1 Middle East & Africa Pemetrexed Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pemetrexed Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Pemetrexed Drug Sales by Type
8.3 Middle East & Africa Pemetrexed Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pemetrexed Drug
10.3 Manufacturing Process Analysis of Pemetrexed Drug
10.4 Industry Chain Structure of Pemetrexed Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pemetrexed Drug Distributors
11.3 Pemetrexed Drug Customer
12 WORLD FORECAST REVIEW FOR PEMETREXED DRUG BY GEOGRAPHIC REGION
12.1 Global Pemetrexed Drug Market Size Forecast by Region
12.1.1 Global Pemetrexed Drug Forecast by Region (2024-2029)
12.1.2 Global Pemetrexed Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pemetrexed Drug Forecast by Type
12.7 Global Pemetrexed Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly and Company
13.1.1 Eli Lilly and Company Company Information
13.1.2 Eli Lilly and Company Pemetrexed Drug Product Portfolios and Specifications
13.1.3 Eli Lilly and Company Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eli Lilly and Company Main Business Overview
13.1.5 Eli Lilly and Company Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Pemetrexed Drug Product Portfolios and Specifications
13.2.3 Pfizer Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Pemetrexed Drug Product Portfolios and Specifications
13.3.3 Teva Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Eagle Pharmaceuticals
13.4.1 Eagle Pharmaceuticals Company Information
13.4.2 Eagle Pharmaceuticals Pemetrexed Drug Product Portfolios and Specifications
13.4.3 Eagle Pharmaceuticals Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Eagle Pharmaceuticals Main Business Overview
13.4.5 Eagle Pharmaceuticals Latest Developments
13.5 APOTEX
13.5.1 APOTEX Company Information
13.5.2 APOTEX Pemetrexed Drug Product Portfolios and Specifications
13.5.3 APOTEX Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 APOTEX Main Business Overview
13.5.5 APOTEX Latest Developments
13.6 Qilu Pharmaceutical
13.6.1 Qilu Pharmaceutical Company Information
13.6.2 Qilu Pharmaceutical Pemetrexed Drug Product Portfolios and Specifications
13.6.3 Qilu Pharmaceutical Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Qilu Pharmaceutical Main Business Overview
13.6.5 Qilu Pharmaceutical Latest Developments
13.7 Biocon
13.7.1 Biocon Company Information
13.7.2 Biocon Pemetrexed Drug Product Portfolios and Specifications
13.7.3 Biocon Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Biocon Main Business Overview
13.7.5 Biocon Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pemetrexed Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pemetrexed Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pemetrexed Drug by Country/Region, 2018, 2022 & 2029
2.2 Pemetrexed Drug Segment by Type
2.2.1 100 mg lyophilized powder/vial
2.2.2 500 mg lyophilized powder/vial
2.3 Pemetrexed Drug Sales by Type
2.3.1 Global Pemetrexed Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Pemetrexed Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pemetrexed Drug Sale Price by Type (2018-2023)
2.4 Pemetrexed Drug Segment by Application
2.4.1 Pleural mesothelioma
2.4.2 Non-small cell lung cancer
2.5 Pemetrexed Drug Sales by Application
2.5.1 Global Pemetrexed Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Pemetrexed Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pemetrexed Drug Sale Price by Application (2018-2023)
3 GLOBAL PEMETREXED DRUG BY COMPANY
3.1 Global Pemetrexed Drug Breakdown Data by Company
3.1.1 Global Pemetrexed Drug Annual Sales by Company (2018-2023)
3.1.2 Global Pemetrexed Drug Sales Market Share by Company (2018-2023)
3.2 Global Pemetrexed Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Pemetrexed Drug Revenue by Company (2018-2023)
3.2.2 Global Pemetrexed Drug Revenue Market Share by Company (2018-2023)
3.3 Global Pemetrexed Drug Sale Price by Company
3.4 Key Manufacturers Pemetrexed Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pemetrexed Drug Product Location Distribution
3.4.2 Players Pemetrexed Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PEMETREXED DRUG BY GEOGRAPHIC REGION
4.1 World Historic Pemetrexed Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Pemetrexed Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pemetrexed Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pemetrexed Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Pemetrexed Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pemetrexed Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pemetrexed Drug Sales Growth
4.4 APAC Pemetrexed Drug Sales Growth
4.5 Europe Pemetrexed Drug Sales Growth
4.6 Middle East & Africa Pemetrexed Drug Sales Growth
5 AMERICAS
5.1 Americas Pemetrexed Drug Sales by Country
5.1.1 Americas Pemetrexed Drug Sales by Country (2018-2023)
5.1.2 Americas Pemetrexed Drug Revenue by Country (2018-2023)
5.2 Americas Pemetrexed Drug Sales by Type
5.3 Americas Pemetrexed Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pemetrexed Drug Sales by Region
6.1.1 APAC Pemetrexed Drug Sales by Region (2018-2023)
6.1.2 APAC Pemetrexed Drug Revenue by Region (2018-2023)
6.2 APAC Pemetrexed Drug Sales by Type
6.3 APAC Pemetrexed Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pemetrexed Drug by Country
7.1.1 Europe Pemetrexed Drug Sales by Country (2018-2023)
7.1.2 Europe Pemetrexed Drug Revenue by Country (2018-2023)
7.2 Europe Pemetrexed Drug Sales by Type
7.3 Europe Pemetrexed Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pemetrexed Drug by Country
8.1.1 Middle East & Africa Pemetrexed Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pemetrexed Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Pemetrexed Drug Sales by Type
8.3 Middle East & Africa Pemetrexed Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pemetrexed Drug
10.3 Manufacturing Process Analysis of Pemetrexed Drug
10.4 Industry Chain Structure of Pemetrexed Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pemetrexed Drug Distributors
11.3 Pemetrexed Drug Customer
12 WORLD FORECAST REVIEW FOR PEMETREXED DRUG BY GEOGRAPHIC REGION
12.1 Global Pemetrexed Drug Market Size Forecast by Region
12.1.1 Global Pemetrexed Drug Forecast by Region (2024-2029)
12.1.2 Global Pemetrexed Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pemetrexed Drug Forecast by Type
12.7 Global Pemetrexed Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly and Company
13.1.1 Eli Lilly and Company Company Information
13.1.2 Eli Lilly and Company Pemetrexed Drug Product Portfolios and Specifications
13.1.3 Eli Lilly and Company Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eli Lilly and Company Main Business Overview
13.1.5 Eli Lilly and Company Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Pemetrexed Drug Product Portfolios and Specifications
13.2.3 Pfizer Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Pemetrexed Drug Product Portfolios and Specifications
13.3.3 Teva Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Eagle Pharmaceuticals
13.4.1 Eagle Pharmaceuticals Company Information
13.4.2 Eagle Pharmaceuticals Pemetrexed Drug Product Portfolios and Specifications
13.4.3 Eagle Pharmaceuticals Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Eagle Pharmaceuticals Main Business Overview
13.4.5 Eagle Pharmaceuticals Latest Developments
13.5 APOTEX
13.5.1 APOTEX Company Information
13.5.2 APOTEX Pemetrexed Drug Product Portfolios and Specifications
13.5.3 APOTEX Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 APOTEX Main Business Overview
13.5.5 APOTEX Latest Developments
13.6 Qilu Pharmaceutical
13.6.1 Qilu Pharmaceutical Company Information
13.6.2 Qilu Pharmaceutical Pemetrexed Drug Product Portfolios and Specifications
13.6.3 Qilu Pharmaceutical Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Qilu Pharmaceutical Main Business Overview
13.6.5 Qilu Pharmaceutical Latest Developments
13.7 Biocon
13.7.1 Biocon Company Information
13.7.2 Biocon Pemetrexed Drug Product Portfolios and Specifications
13.7.3 Biocon Pemetrexed Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Biocon Main Business Overview
13.7.5 Biocon Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pemetrexed Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pemetrexed Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 100 mg lyophilized powder/vial
Table 4. Major Players of 500 mg lyophilized powder/vial
Table 5. Global Pemetrexed Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global Pemetrexed Drug Sales Market Share by Type (2018-2023)
Table 7. Global Pemetrexed Drug Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pemetrexed Drug Revenue Market Share by Type (2018-2023)
Table 9. Global Pemetrexed Drug Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Pemetrexed Drug Sales by Application (2018-2023) & (K Units)
Table 11. Global Pemetrexed Drug Sales Market Share by Application (2018-2023)
Table 12. Global Pemetrexed Drug Revenue by Application (2018-2023)
Table 13. Global Pemetrexed Drug Revenue Market Share by Application (2018-2023)
Table 14. Global Pemetrexed Drug Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Pemetrexed Drug Sales by Company (2018-2023) & (K Units)
Table 16. Global Pemetrexed Drug Sales Market Share by Company (2018-2023)
Table 17. Global Pemetrexed Drug Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pemetrexed Drug Revenue Market Share by Company (2018-2023)
Table 19. Global Pemetrexed Drug Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Pemetrexed Drug Producing Area Distribution and Sales Area
Table 21. Players Pemetrexed Drug Products Offered
Table 22. Pemetrexed Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pemetrexed Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Pemetrexed Drug Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pemetrexed Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pemetrexed Drug Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pemetrexed Drug Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Pemetrexed Drug Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pemetrexed Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pemetrexed Drug Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pemetrexed Drug Sales by Country (2018-2023) & (K Units)
Table 34. Americas Pemetrexed Drug Sales Market Share by Country (2018-2023)
Table 35. Americas Pemetrexed Drug Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pemetrexed Drug Revenue Market Share by Country (2018-2023)
Table 37. Americas Pemetrexed Drug Sales by Type (2018-2023) & (K Units)
Table 38. Americas Pemetrexed Drug Sales by Application (2018-2023) & (K Units)
Table 39. APAC Pemetrexed Drug Sales by Region (2018-2023) & (K Units)
Table 40. APAC Pemetrexed Drug Sales Market Share by Region (2018-2023)
Table 41. APAC Pemetrexed Drug Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pemetrexed Drug Revenue Market Share by Region (2018-2023)
Table 43. APAC Pemetrexed Drug Sales by Type (2018-2023) & (K Units)
Table 44. APAC Pemetrexed Drug Sales by Application (2018-2023) & (K Units)
Table 45. Europe Pemetrexed Drug Sales by Country (2018-2023) & (K Units)
Table 46. Europe Pemetrexed Drug Sales Market Share by Country (2018-2023)
Table 47. Europe Pemetrexed Drug Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pemetrexed Drug Revenue Market Share by Country (2018-2023)
Table 49. Europe Pemetrexed Drug Sales by Type (2018-2023) & (K Units)
Table 50. Europe Pemetrexed Drug Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Pemetrexed Drug Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Pemetrexed Drug Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pemetrexed Drug Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pemetrexed Drug Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pemetrexed Drug Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Pemetrexed Drug Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Pemetrexed Drug
Table 58. Key Market Challenges & Risks of Pemetrexed Drug
Table 59. Key Industry Trends of Pemetrexed Drug
Table 60. Pemetrexed Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pemetrexed Drug Distributors List
Table 63. Pemetrexed Drug Customer List
Table 64. Global Pemetrexed Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Pemetrexed Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pemetrexed Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Pemetrexed Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pemetrexed Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Pemetrexed Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pemetrexed Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Pemetrexed Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pemetrexed Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Pemetrexed Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pemetrexed Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Pemetrexed Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pemetrexed Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Pemetrexed Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Eli Lilly and Company Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Eli Lilly and Company Pemetrexed Drug Product Portfolios and Specifications
Table 80. Eli Lilly and Company Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Eli Lilly and Company Main Business
Table 82. Eli Lilly and Company Latest Developments
Table 83. Pfizer Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Pemetrexed Drug Product Portfolios and Specifications
Table 85. Pfizer Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Teva Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pemetrexed Drug Product Portfolios and Specifications
Table 90. Teva Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Teva Main Business
Table 92. Teva Latest Developments
Table 93. Eagle Pharmaceuticals Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Eagle Pharmaceuticals Pemetrexed Drug Product Portfolios and Specifications
Table 95. Eagle Pharmaceuticals Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Eagle Pharmaceuticals Main Business
Table 97. Eagle Pharmaceuticals Latest Developments
Table 98. APOTEX Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. APOTEX Pemetrexed Drug Product Portfolios and Specifications
Table 100. APOTEX Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. APOTEX Main Business
Table 102. APOTEX Latest Developments
Table 103. Qilu Pharmaceutical Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Qilu Pharmaceutical Pemetrexed Drug Product Portfolios and Specifications
Table 105. Qilu Pharmaceutical Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Qilu Pharmaceutical Main Business
Table 107. Qilu Pharmaceutical Latest Developments
Table 108. Biocon Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Biocon Pemetrexed Drug Product Portfolios and Specifications
Table 110. Biocon Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Biocon Main Business
Table 112. Biocon Latest Developments
Table 1. Pemetrexed Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pemetrexed Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 100 mg lyophilized powder/vial
Table 4. Major Players of 500 mg lyophilized powder/vial
Table 5. Global Pemetrexed Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global Pemetrexed Drug Sales Market Share by Type (2018-2023)
Table 7. Global Pemetrexed Drug Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pemetrexed Drug Revenue Market Share by Type (2018-2023)
Table 9. Global Pemetrexed Drug Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Pemetrexed Drug Sales by Application (2018-2023) & (K Units)
Table 11. Global Pemetrexed Drug Sales Market Share by Application (2018-2023)
Table 12. Global Pemetrexed Drug Revenue by Application (2018-2023)
Table 13. Global Pemetrexed Drug Revenue Market Share by Application (2018-2023)
Table 14. Global Pemetrexed Drug Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Pemetrexed Drug Sales by Company (2018-2023) & (K Units)
Table 16. Global Pemetrexed Drug Sales Market Share by Company (2018-2023)
Table 17. Global Pemetrexed Drug Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pemetrexed Drug Revenue Market Share by Company (2018-2023)
Table 19. Global Pemetrexed Drug Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Pemetrexed Drug Producing Area Distribution and Sales Area
Table 21. Players Pemetrexed Drug Products Offered
Table 22. Pemetrexed Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pemetrexed Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Pemetrexed Drug Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pemetrexed Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pemetrexed Drug Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pemetrexed Drug Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Pemetrexed Drug Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pemetrexed Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pemetrexed Drug Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pemetrexed Drug Sales by Country (2018-2023) & (K Units)
Table 34. Americas Pemetrexed Drug Sales Market Share by Country (2018-2023)
Table 35. Americas Pemetrexed Drug Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pemetrexed Drug Revenue Market Share by Country (2018-2023)
Table 37. Americas Pemetrexed Drug Sales by Type (2018-2023) & (K Units)
Table 38. Americas Pemetrexed Drug Sales by Application (2018-2023) & (K Units)
Table 39. APAC Pemetrexed Drug Sales by Region (2018-2023) & (K Units)
Table 40. APAC Pemetrexed Drug Sales Market Share by Region (2018-2023)
Table 41. APAC Pemetrexed Drug Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pemetrexed Drug Revenue Market Share by Region (2018-2023)
Table 43. APAC Pemetrexed Drug Sales by Type (2018-2023) & (K Units)
Table 44. APAC Pemetrexed Drug Sales by Application (2018-2023) & (K Units)
Table 45. Europe Pemetrexed Drug Sales by Country (2018-2023) & (K Units)
Table 46. Europe Pemetrexed Drug Sales Market Share by Country (2018-2023)
Table 47. Europe Pemetrexed Drug Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pemetrexed Drug Revenue Market Share by Country (2018-2023)
Table 49. Europe Pemetrexed Drug Sales by Type (2018-2023) & (K Units)
Table 50. Europe Pemetrexed Drug Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Pemetrexed Drug Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Pemetrexed Drug Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pemetrexed Drug Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pemetrexed Drug Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pemetrexed Drug Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Pemetrexed Drug Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Pemetrexed Drug
Table 58. Key Market Challenges & Risks of Pemetrexed Drug
Table 59. Key Industry Trends of Pemetrexed Drug
Table 60. Pemetrexed Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pemetrexed Drug Distributors List
Table 63. Pemetrexed Drug Customer List
Table 64. Global Pemetrexed Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Pemetrexed Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pemetrexed Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Pemetrexed Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pemetrexed Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Pemetrexed Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pemetrexed Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Pemetrexed Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pemetrexed Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Pemetrexed Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pemetrexed Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Pemetrexed Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pemetrexed Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Pemetrexed Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Eli Lilly and Company Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Eli Lilly and Company Pemetrexed Drug Product Portfolios and Specifications
Table 80. Eli Lilly and Company Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Eli Lilly and Company Main Business
Table 82. Eli Lilly and Company Latest Developments
Table 83. Pfizer Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Pemetrexed Drug Product Portfolios and Specifications
Table 85. Pfizer Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Teva Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pemetrexed Drug Product Portfolios and Specifications
Table 90. Teva Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Teva Main Business
Table 92. Teva Latest Developments
Table 93. Eagle Pharmaceuticals Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Eagle Pharmaceuticals Pemetrexed Drug Product Portfolios and Specifications
Table 95. Eagle Pharmaceuticals Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Eagle Pharmaceuticals Main Business
Table 97. Eagle Pharmaceuticals Latest Developments
Table 98. APOTEX Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. APOTEX Pemetrexed Drug Product Portfolios and Specifications
Table 100. APOTEX Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. APOTEX Main Business
Table 102. APOTEX Latest Developments
Table 103. Qilu Pharmaceutical Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Qilu Pharmaceutical Pemetrexed Drug Product Portfolios and Specifications
Table 105. Qilu Pharmaceutical Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Qilu Pharmaceutical Main Business
Table 107. Qilu Pharmaceutical Latest Developments
Table 108. Biocon Basic Information, Pemetrexed Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Biocon Pemetrexed Drug Product Portfolios and Specifications
Table 110. Biocon Pemetrexed Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Biocon Main Business
Table 112. Biocon Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pemetrexed Drug
Figure 2. Pemetrexed Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pemetrexed Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pemetrexed Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pemetrexed Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 100 mg lyophilized powder/vial
Figure 10. Product Picture of 500 mg lyophilized powder/vial
Figure 11. Global Pemetrexed Drug Sales Market Share by Type in 2022
Figure 12. Global Pemetrexed Drug Revenue Market Share by Type (2018-2023)
Figure 13. Pemetrexed Drug Consumed in Pleural mesothelioma
Figure 14. Global Pemetrexed Drug Market: Pleural mesothelioma (2018-2023) & (K Units)
Figure 15. Pemetrexed Drug Consumed in Non-small cell lung cancer
Figure 16. Global Pemetrexed Drug Market: Non-small cell lung cancer (2018-2023) & (K Units)
Figure 17. Global Pemetrexed Drug Sales Market Share by Application (2022)
Figure 18. Global Pemetrexed Drug Revenue Market Share by Application in 2022
Figure 19. Pemetrexed Drug Sales Market by Company in 2022 (K Units)
Figure 20. Global Pemetrexed Drug Sales Market Share by Company in 2022
Figure 21. Pemetrexed Drug Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Pemetrexed Drug Revenue Market Share by Company in 2022
Figure 23. Global Pemetrexed Drug Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Pemetrexed Drug Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Pemetrexed Drug Sales 2018-2023 (K Units)
Figure 26. Americas Pemetrexed Drug Revenue 2018-2023 ($ Millions)
Figure 27. APAC Pemetrexed Drug Sales 2018-2023 (K Units)
Figure 28. APAC Pemetrexed Drug Revenue 2018-2023 ($ Millions)
Figure 29. Europe Pemetrexed Drug Sales 2018-2023 (K Units)
Figure 30. Europe Pemetrexed Drug Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Pemetrexed Drug Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Pemetrexed Drug Revenue 2018-2023 ($ Millions)
Figure 33. Americas Pemetrexed Drug Sales Market Share by Country in 2022
Figure 34. Americas Pemetrexed Drug Revenue Market Share by Country in 2022
Figure 35. Americas Pemetrexed Drug Sales Market Share by Type (2018-2023)
Figure 36. Americas Pemetrexed Drug Sales Market Share by Application (2018-2023)
Figure 37. United States Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Pemetrexed Drug Sales Market Share by Region in 2022
Figure 42. APAC Pemetrexed Drug Revenue Market Share by Regions in 2022
Figure 43. APAC Pemetrexed Drug Sales Market Share by Type (2018-2023)
Figure 44. APAC Pemetrexed Drug Sales Market Share by Application (2018-2023)
Figure 45. China Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Pemetrexed Drug Sales Market Share by Country in 2022
Figure 53. Europe Pemetrexed Drug Revenue Market Share by Country in 2022
Figure 54. Europe Pemetrexed Drug Sales Market Share by Type (2018-2023)
Figure 55. Europe Pemetrexed Drug Sales Market Share by Application (2018-2023)
Figure 56. Germany Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Pemetrexed Drug Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Pemetrexed Drug Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Pemetrexed Drug Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Pemetrexed Drug Sales Market Share by Application (2018-2023)
Figure 65. Egypt Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Pemetrexed Drug in 2022
Figure 71. Manufacturing Process Analysis of Pemetrexed Drug
Figure 72. Industry Chain Structure of Pemetrexed Drug
Figure 73. Channels of Distribution
Figure 74. Global Pemetrexed Drug Sales Market Forecast by Region (2024-2029)
Figure 75. Global Pemetrexed Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Pemetrexed Drug Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Pemetrexed Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Pemetrexed Drug Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Pemetrexed Drug Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pemetrexed Drug
Figure 2. Pemetrexed Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pemetrexed Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pemetrexed Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pemetrexed Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 100 mg lyophilized powder/vial
Figure 10. Product Picture of 500 mg lyophilized powder/vial
Figure 11. Global Pemetrexed Drug Sales Market Share by Type in 2022
Figure 12. Global Pemetrexed Drug Revenue Market Share by Type (2018-2023)
Figure 13. Pemetrexed Drug Consumed in Pleural mesothelioma
Figure 14. Global Pemetrexed Drug Market: Pleural mesothelioma (2018-2023) & (K Units)
Figure 15. Pemetrexed Drug Consumed in Non-small cell lung cancer
Figure 16. Global Pemetrexed Drug Market: Non-small cell lung cancer (2018-2023) & (K Units)
Figure 17. Global Pemetrexed Drug Sales Market Share by Application (2022)
Figure 18. Global Pemetrexed Drug Revenue Market Share by Application in 2022
Figure 19. Pemetrexed Drug Sales Market by Company in 2022 (K Units)
Figure 20. Global Pemetrexed Drug Sales Market Share by Company in 2022
Figure 21. Pemetrexed Drug Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Pemetrexed Drug Revenue Market Share by Company in 2022
Figure 23. Global Pemetrexed Drug Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Pemetrexed Drug Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Pemetrexed Drug Sales 2018-2023 (K Units)
Figure 26. Americas Pemetrexed Drug Revenue 2018-2023 ($ Millions)
Figure 27. APAC Pemetrexed Drug Sales 2018-2023 (K Units)
Figure 28. APAC Pemetrexed Drug Revenue 2018-2023 ($ Millions)
Figure 29. Europe Pemetrexed Drug Sales 2018-2023 (K Units)
Figure 30. Europe Pemetrexed Drug Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Pemetrexed Drug Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Pemetrexed Drug Revenue 2018-2023 ($ Millions)
Figure 33. Americas Pemetrexed Drug Sales Market Share by Country in 2022
Figure 34. Americas Pemetrexed Drug Revenue Market Share by Country in 2022
Figure 35. Americas Pemetrexed Drug Sales Market Share by Type (2018-2023)
Figure 36. Americas Pemetrexed Drug Sales Market Share by Application (2018-2023)
Figure 37. United States Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Pemetrexed Drug Sales Market Share by Region in 2022
Figure 42. APAC Pemetrexed Drug Revenue Market Share by Regions in 2022
Figure 43. APAC Pemetrexed Drug Sales Market Share by Type (2018-2023)
Figure 44. APAC Pemetrexed Drug Sales Market Share by Application (2018-2023)
Figure 45. China Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Pemetrexed Drug Sales Market Share by Country in 2022
Figure 53. Europe Pemetrexed Drug Revenue Market Share by Country in 2022
Figure 54. Europe Pemetrexed Drug Sales Market Share by Type (2018-2023)
Figure 55. Europe Pemetrexed Drug Sales Market Share by Application (2018-2023)
Figure 56. Germany Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Pemetrexed Drug Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Pemetrexed Drug Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Pemetrexed Drug Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Pemetrexed Drug Sales Market Share by Application (2018-2023)
Figure 65. Egypt Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Pemetrexed Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Pemetrexed Drug in 2022
Figure 71. Manufacturing Process Analysis of Pemetrexed Drug
Figure 72. Industry Chain Structure of Pemetrexed Drug
Figure 73. Channels of Distribution
Figure 74. Global Pemetrexed Drug Sales Market Forecast by Region (2024-2029)
Figure 75. Global Pemetrexed Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Pemetrexed Drug Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Pemetrexed Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Pemetrexed Drug Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Pemetrexed Drug Revenue Market Share Forecast by Application (2024-2029)
